Overview

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Status:
RECRUITING
Trial end date:
2029-07-24
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy of treatment FOLFORINOX 3 in first-line therapy for patients with locally advanced unresectable or metastatic pancreatic cancer.
Phase:
PHASE2
Details
Lead Sponsor:
Centre Georges Francois Leclerc